I can assure you that the Government is committed to improving survival rates for people with cancer.
I understand that national prescribing arrangements already allow for bisphosphonates to be prescribed for the treatment and prevention of secondary breast cancer. Decisions about the funding of bisphosphonates for this use are rightly taken by local clinical commissioning groups which are best placed to know what local need exists.
Continued on PDF...